Fundraising Fox

Mathias Frederiksen

Investor

Principal at Novartis Venture Fund

Basel, Switzerland

Writes $5M – $10M checks · typically $7.5M

About

Mathias Frederiksen is a Principal at the Novartis Venture Fund, based in Basel. Before joining NVF, he was a group leader in Novartis R&D, where his work covered neuroscience-focused medicinal chemistry, chemical genomics, and target discovery, with a focus on epigenetic dysregulation in disease, and he served on the portfolio management and strategy team. He holds a BSc in Chemistry from Mount Allison University, a PhD in Chemistry from Imperial College London, and completed a postdoctorate at Stanford University.

LinkedIn ↗

Experience

  1. Novartis Venture FundPrincipalcurrent2023 — presentBasel, Switzerland
  2. Novartis Venture FundAssociate2022 — 2023Basel, Switzerland
  3. AravaxDirector Board of Directorscurrent2026 — present
  4. NRG TherapeuticsBoard Observercurrent2025 — presentStevenage, England, United Kingdom
  5. Averna TherapeuticsBoard Observercurrent2024 — presentBoston, Massachusetts, United States
  6. UZH Life Sciences FundInvestment Managercurrent2022 — presentZurich, Switzerland
  7. LoQus23 Therapeutics LtdBoard Observercurrent2022 — presentCambridge, England, United Kingdom
  8. FundaMental PharmaDirector Board of Directors2023 — 2025Heidelberg, Baden-Württemberg, Germany
  9. Para TherapeuticsBoard Observer2023 — 2025San Francisco Bay Area
  10. Novartis Institutes for BioMedical Research (NIBR)Associate Director and Group Leader Chomatin Chemical Biology2020 — 2022Basel Area, Switzerland
  11. Novartis Institutes for BioMedical Research (NIBR)Senior Investigator II2018 — 2020Basel Area, Switzerland
  12. Novartis Institutes for BioMedical Research (NIBR)Senior Investigator I2014 — 2018Basel Area, Switzerland
  13. Novartis Institutes for BioMedical Research (NIBR)Investigator III2010 — 2014
  14. Novartis Institutes for BioMedical Research (NIBR)Research Investigator II2007 — 2009
  15. Novartis Institutes for BioMedical Research (NIBR)Research Investigator I2005 — 2007
  16. Stanford UniversityPost-doctoral Research Investigator2003 — 2004
  17. Imperial College LondonPhD Candidate1998 — 2002

Education

  1. Stanford UniversityPost-Doc, Chemistry2002 — 2004
  2. Imperial College LondonPhD, Synthetic Organic Chemistry1998 — 2002
  3. Mount Allison UniversityB.Sc, Chemistry1995 — 1998
  4. UWC Atlantic CollegeInternational Baccalaureate1992 — 1994

Skills & more

Start-up Ventures4Corporate Venture Capital5Company build3Venture CapitalVenture FinancingFinanceEpigenetics11Medicinal Chemistry80Drug Design68Organic Synthesis47Drug Discovery99Life Sciences20
+12 moreProteomicsCell Based AssaysOrganic ChemistrySignal TransductionTarget IdentificationLifesciencesPharmaceutical IndustryLead ChangeAssay DevelopmentDrug DevelopmentCellGPCRs

Languages English · French · German · Norwegian

From Mathias's professional profile.

Same school

Also attended Stanford University1,578

Peter ThielCo-founder & Partner at Founders FundReid HoffmanCo-founder of LinkedIn; Partner at GreylockDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarKeith RaboisManaging Director at Khosla VenturesGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia Capital

+ 1,572 more

Also attended Imperial College London295

Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniPauline BoucherInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at Medicxi

+ 289 more

Also attended Mount Allison University12

Anamitra DebSenior Vice President, Programs and Policy at Omidyar NetworkDonna ParrManaging Partner at Cross-Border Impact VenturesSarah YoungFounding and Managing Partner at Sandpiper VenturesBarbara M. CampbellRegional Director, NPC-Atlantic Canada at Natural Products CanadaAnnie ThériaultManaging Partner at Cross-Border Impact VenturesKennedy WryCommunications & Engagement Coordinator at Centre for Entrepreneurship Education & Development (CEED)

+ 6 more

Also attended UWC Atlantic College12

Noah FreyFinance Analyst at Emerald Technology Ventures AgFaris AyoubPartner, Helios Sports and Entertainment Group at Helios Digital VenturesHaakon OverliGeneral Partner at Dawn Capital LLPTomás Álvarez BelónInvestor at Innovation EndeavorsMatthias SchanzeGeneral Partner at Rethink VenturesJimmy DietzPartner at V3 Ventures

+ 6 more

Shared employers

Also worked at Aravax2

Joey ManInvestment Associate at TenmileAizaz SyedSenior Portfolio and Investment Manager at Tenmile

Also worked at Averna Therapeutics3

Nick OlsenPrincipal at Innovation EndeavorsEric HuangPartner at Delos CapitalDylan MorrisManaging Director at Insight Partners

Also worked at UZH Life Sciences Fund3

Bart DzikowskiManaging Director, Head of Transactions & Legal at Novartis Venture FundBeat SteffenManaging Director at Novartis Venture FundMichio PainterPartner at Ataraxia VC

Also worked at Novartis Institutes for BioMedical Research (NIBR)105

Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures

+ 99 more

Colleagues at Novartis Venture Fund

Aaron Nelson
Managing Director at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund